GoodRx Holdings, Inc. (GDRX)
Health Care · Digital healthcare platform / prescription affordability solutions · Nasdaq
GoodRx is a consumer-focused digital healthcare platform that provides price transparency, prescription savings, and affordability solutions across the U.S. healthcare ecosystem.
What GoodRx Holdings, Inc. does
GoodRx is a digital healthcare platform that helps American consumers save time and money when filling prescriptions through a price comparison tool that processes over 420 billion pricing data points daily. The platform provides dynamic, geographically relevant prescription pricing and access to negotiated prices through GoodRx codes, enabling significant savings on generic and brand medications. Beyond prescription price comparison, GoodRx has expanded to offer telehealth services, wellness content, and condition-specific end-to-end solutions for consumers and healthcare providers. The company generates revenue by serving as an essential access and affordability layer across the healthcare ecosystem, monetizing at different stages of the consumer healthcare journey.
Themes: ["Prescription price transparency / affordability","Digital healthcare platform","Telehealth","Consumer health engagement","Healthcare cost reduction / medication access"]
Fundamentals
- Price$2.95 as of 2026-07-10 close
- Market cap$999M as of 2026-07-13
- 1-year return-39.8% as of 2026-07-10 close
- P/E48.60 as of 2026-07-13
- Net margin+2.6% as of 2026-07-13
- Gross margin+91.8% as of 2026-07-13
- ROE+3.3% as of 2026-07-13
- Debt / equity0.78 as of 2026-07-13
- Revenue growth (YoY)-1.2% as of 2026-07-13
- Revenue CAGR (3y)+1.3% SEC XBRL
- Beta1.60 as of 2026-07-13
Key risks (from latest filing)
["Government healthcare initiatives like TrumpRx.gov and Most-Favored-Nation pricing policies may significantly impact GoodRx's business model and competitive positioning; the impact remains unclear as of early 2026.","Continued shifts in healthcare costs to consumers through Medicaid cuts (One Big Beautiful Bill Act), copay increases, and ACA marketplace subsidy changes could alter demand patterns and consumer behavior unpredictably.","Revenue decline of -1.19% YoY and -39.8% stock price return over the past year suggest market headwinds, potential loss of consumer adoption momentum, or margin pressure from competitive or regulatory forces."]
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.